Source:http://linkedlifedata.com/resource/pubmed/id/15039764
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004781,
umls-concept:C0024487,
umls-concept:C0025235,
umls-concept:C0033727,
umls-concept:C0040383,
umls-concept:C0233401,
umls-concept:C0332281,
umls-concept:C0457801,
umls-concept:C0870883,
umls-concept:C1384671,
umls-concept:C1413973,
umls-concept:C1515926,
umls-concept:C1706077,
umls-concept:C2349188,
umls-concept:C2603343
|
pubmed:issue |
5
|
pubmed:dateCreated |
2004-4-20
|
pubmed:abstractText |
Long-term toluene abuse causes a variety of psychiatric symptoms. However, little is known about abnormalities at the neurochemical level in the living human brain after long-term exposure to toluene. To detect neurochemical changes in the basal ganglia of subjects with a history of long-term toluene use, proton magnetic resonance spectroscopy (1H MRS) was performed in 12 abstinent toluene users and 13 healthy comparisons with no history of drug abuse. N-acetylaspartate (NAA), creatine plus phosphocreatine (Cr + PCr), choline-containing compounds (Cho), and myo-inositol (MI) levels were measured in the left and right basal ganglia. The Cho/Cr + PCr ratio, a marker of membrane metabolism, was significantly increased in the basal ganglia of toluene users in comparison to that of the control subjects. Furthermore, the increase in the Cho/Cr + PCr ratio was significantly correlated with the severity of residual psychiatric symptoms. These findings suggest that long-term toluene use causes membrane disturbance in the basal ganglia, which is associated with residual psychiatric symptoms that persist even after long-term abstinence from toluene use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0893-133X
|
pubmed:author |
pubmed-author:IsodaHaruoH,
pubmed-author:IwataYasuhideY,
pubmed-author:MinabeYoshioY,
pubmed-author:MoriNorioN,
pubmed-author:NakamuraKazuhikoK,
pubmed-author:NishimuraKatsuhikoK,
pubmed-author:SakaharaHarumiH,
pubmed-author:SekineYoshimotoY,
pubmed-author:SuzukiKatsuakiK,
pubmed-author:TakebayashiKiyokazuK,
pubmed-author:TakedaHiroyasuH,
pubmed-author:TakeiNoriN
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1019-26
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:15039764-Adult,
pubmed-meshheading:15039764-Antipsychotic Agents,
pubmed-meshheading:15039764-Basal Ganglia,
pubmed-meshheading:15039764-Biological Markers,
pubmed-meshheading:15039764-Female,
pubmed-meshheading:15039764-Humans,
pubmed-meshheading:15039764-Magnetic Resonance Spectroscopy,
pubmed-meshheading:15039764-Male,
pubmed-meshheading:15039764-Psychiatric Status Rating Scales,
pubmed-meshheading:15039764-Substance Withdrawal Syndrome,
pubmed-meshheading:15039764-Substance-Related Disorders,
pubmed-meshheading:15039764-Toluene
|
pubmed:year |
2004
|
pubmed:articleTitle |
Metabolite alterations in basal ganglia associated with psychiatric symptoms of abstinent toluene users: a proton MRS study.
|
pubmed:affiliation |
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|